113 related articles for article (PubMed ID: 18588853)
1. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
Hikami K; Ehara Y; Hasegawa M; Fujimoto M; Matsushita M; Oka T; Takehara K; Sato S; Tokunaga K; Tsuchiya N
Biochem Biophys Res Commun; 2008 Aug; 373(3):403-7. PubMed ID: 18588853
[TBL] [Abstract][Full Text] [Related]
2. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
3. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
4. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
[TBL] [Abstract][Full Text] [Related]
5. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
Beretta L; Cappiello F; Barili M; Scorza R
Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
[TBL] [Abstract][Full Text] [Related]
6. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
[TBL] [Abstract][Full Text] [Related]
8. Association of the FAM167A-BLK region with systemic sclerosis.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
[TBL] [Abstract][Full Text] [Related]
9. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
[TBL] [Abstract][Full Text] [Related]
10. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.
Beretta L; Bertolotti F; Cappiello F; Barili M; Masciocchi M; Toussoun K; Caronni M; Scorza R
Hum Immunol; 2007 Jul; 68(7):603-9. PubMed ID: 17584583
[TBL] [Abstract][Full Text] [Related]
13. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
14. Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
Yoo KH; Kim SK; Chung JH; Chang SG
J Korean Med Sci; 2011 May; 26(5):659-64. PubMed ID: 21532858
[TBL] [Abstract][Full Text] [Related]
15. TCRBV20S1 and TCRBV3S1 gene segment polymorphisms in systemic sclerosis.
Bredemeier M; Chies JA; Wieck A; Capobianco KG; Pitrez EH; Rohde LE; Pinotti AF; Brenol JC; Xavier RM
J Rheumatol; 2008 Jun; 35(6):1058-63. PubMed ID: 18412309
[TBL] [Abstract][Full Text] [Related]
16. Increased serum soluble CD40 levels in patients with systemic sclerosis.
Komura K; Fujimoto M; Matsushita T; Yanaba K; Kodera M; Kawasuji A; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
[TBL] [Abstract][Full Text] [Related]
17. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
18. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
19. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
Alizadeh BZ; Broen J; Rueda B; Hesselstrand R; Wuttge D; Simeon C; Ortego-Centeno N; Gonzalez-Gay MA; Pros A; Herrick A; Worthington J; Denton C; Fonseca C; Riemekasten G; Vonk MC; van den Hoogen F; Guiducci S; Matucci-Cerinic M; Scorza R; Beretta L; Airó P; Coenen M; Martin J; Koeleman BP; Radstake TR;
J Rheumatol; 2010 Aug; 37(8):1673-9. PubMed ID: 20551103
[TBL] [Abstract][Full Text] [Related]
20. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
Carulli MT; Handler C; Coghlan JG; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
